Effectiveness of budesonide nebulising suspension compared to disodium cromoglycate in early childhood asthma

Current Medical Research and Opinion

Volumn 22, Issue 2, 2006, Pages 367-373

  Zielen, S ^a   Rose, Markus A ^a   Bez, C ^a   Jarisch, A ^a   Reichenbach, J ^a   Hofmann, D ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Asthma; Disodium cromoglycate; Growth; Nebulised budesonide; Preschool children

Indexed keywords

AUTACOID; BRONCHODILATING AGENT; BUDESONIDE; CROMOGLYCATE DISODIUM; PREDNISONE; SALBUTAMOL; SHORT ACTING DRUG; STEROID; ANTIASTHMATIC AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DEMOGRAPHY; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DYSPNEA; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MILD PERSISTENT ASTHMA; NEBULIZATION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REVIEW; WHEEZING; ARTICLE; ASTHMA; COMPARATIVE STUDY; GERMANY; NEBULIZER; TREATMENT OUTCOME;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD, PRESCHOOL; CROMOLYN SODIUM; DOUBLE-BLIND METHOD; FEMALE; GERMANY; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME;

EID: 33645745997     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X89739     Document Type: Article

References (31)

1. Anderson HR, Pottier AC, Strachan DP. Asthma from birth to age 23: incidence and relation to prior and concurrent atopic disease. Thorax 1992;47:537-42
2. Luyt DK, Burton PR, Simpson H. Epidemiological study of wheeze, doctor diagnosed asthma, and cough in preschool children in Leicestershire. BMJ 1993;306:1386-90
3. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995;332:133-8
4. Carlsen KH. What distinguishes the asthmatic amongst the infant wheezers? Pediatr Allergy Immunol 1997;8(Suppl):40-5
5. Martinez FD. Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 1999;104:169-74
6. Tabachnik E, Levison H. Postgraduate course presentation. Infantile bronchial asthma. J Allergy Clin Immunol 1981;67: 339-47
7. Koller DY, Wojnarowski C, Herkner KR, et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol 1997;99:752-6
8. Laitinen LA, Altraja A, Karjalainen EM, et al. Early interventions in asthma with inhaled corticosteroids. J Allergy Clin Immunol 2000;105:5582-5
9. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Chest 1995;108:1228-34
10. Selroos O, Pietinalho A, Lofroos AB, et al. Effect of early versus late intervention with inhaled corticosteroids in asthma. Thorax 1998;53:933-8
11. Mintz M. Asthma update: part II. Medical management. Am Fam Physicians 2004;70:1061-6
12. Tasche MJ, van der Wouden JC, Uijen JH, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma. Lancet 1997;350:1060-4
13. Tasche MJ, Uijen JH, Bernsen RM, et al. Inhaled sodium cromoglycate in children with asthma. Thorax 2002;57:751-2
14. Tasche MJ, Uijen JH, Bernsen RM, et al. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 2000;55:913-20
15. De Blic J, Delacourt C, Le Bourgeois M, et al. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996;98:14-20
16. Liu AH. Consider the child: how early should we treat? Lancet 2003;361:1071-6
17. Bahceciler NN, Barlan IB, Nuhoglu Y, et al. Which factors predict success after discontinuation of inhaled budesonide therapy in children with asthma? J Asthma 2002;39:37-46
18. Visser MJ, Postma DS, Arends LR, et al. One-year treatment with different dosing schedules of fluticasone propionate in childhood asthma. Effects on hyperresponsiveness, lung function, and height. Am J Respir Crit Care Med 2001;164:2073-7
19. Agertoft L, Pedersen S. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000;343: 1054-63
20. Leflein JG, Szefler SJ, Murphy KR, et al. Nebulized budesonide inhalation suspension compared with cromolyn sodium nebulizer solution for asthma in young children: results of a randomized outcomes trial. Pediatrics 2002;109: 866-72
21. Fujisawa T, Terada A, Atsuta J, et al. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma. Clin Exp Allergy 1998;28:19-25
22. Ingram JM, Rakes GP, Hoover GE, et al. Eosinophil cationic protein in serum and nasal washes from wheezing infants and children. J Pediatr 1995;127:558-64
23. Oymar K, Bjerknes R. Is serum eosinophil cationic protein in bronchiolitis a predictor of asthma? Pediatr Allergy Immunol 1998;9:204-7
24. Vanto T, Koskinen P. Serum eosinophil cationic protein in the evaluation of asthma severity in children. Allergy 1998;53:415-9
25. Martinez FD. Recognizing early asthma. Allergy 1999;54 (Suppl 49):24-8
26. Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med 2001;164:738-43
27. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-7
28. Van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, et al. Remission of childhood asthma after long-term treatment with an inhaled corticosteroid (budesonide): can it be achieved? Dutch CNSLD Study Group. Eur Respir J 1994;7:63-8
29. Halterman JS, Szilagyi PG, Yoos HL, et al. Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Arch Pediatr Adolesc Med 2004 158:460-7
30. Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002;109(Suppl):373-80
31. Bisgaard H, Allen D, Milanowski J. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:e87-94